Corrigendum: Bibliometric analysis of evolutionary trends and hotspots of super-enhancers in cancer

Front Pharmacol. 2023 Sep 5:14:1285522. doi: 10.3389/fphar.2023.1285522. eCollection 2023.

Zhen-Chu Tang^#^{1

2}, Qiang Qu^#^{3

4

5

6}, Xin-Qi Teng⁷, Hai-Hui Zhuang⁷, Wei-Xin Xu⁷, Jian Qu⁷

¹ Department of Neurology, The Second Xiangya Hospital of Central South University, Changsha, China.
² Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital of Central South University, Changsha, China.
³ Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, China.
⁴ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
⁵ Institute of Hospital Management, Central South University, Changsha, China.
⁶ Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, China.
⁷ Department of Pharmacy, The Second Xiangya Hospital, Institute of Clinical Pharmacy, Central South University, Changsha, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fphar.2023.1192855.].

Keywords: bibliometric analysis; cancer; hot spots; super-enhancer; trends.